Lv5
970 积分 2024-04-17 加入
Adverse events associated with nilotinib in chronic myeloid leukemia: mechanisms and management strategies
25天前
已完结
Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia
25天前
已完结
Cardiovascular Toxicities of Tyrosine Kinase Inhibitor in CML
25天前
已完结
Gastrointestinal stromal tumours
28天前
已完结
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
28天前
已完结
Sab mediates mitochondrial dysfunction involved in imatinib mesylate-induced cardiotoxicity
1个月前
已完结
Comprehensive management of MET tyrosine kinase inhibitor-induced peripheral edema in patients with MET-altered non-small-cell lung cancer: a narrative review
1个月前
已完结
Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors
1个月前
已完结
Acute lymphoblastic leukaemia
1个月前
已完结
[Autoimmune pulmonary alveolar proteinosis induced by brigatinib: a case report and literature review]
1个月前
已完结
皖公网安备34019202002308
